---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-000076"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-01-03T23:59:59+00:00"
generated_at: "2026-05-28T13:52:08.940435+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharma grants 7,500 options to directors and 10,000 RSUs to each top executive

## Summary
- Non-employee directors each received 7,500 options at $2.68, vesting over three years.
- CEO Amy Trombly granted 10,000 RSUs; vesting at 6, 18, and 24 months.
- CFO Jerry Dvonch and COO Bruce Thornton each granted 10,000 RSUs with same vesting schedule.
- All awards vest upon change of control as part of annual equity grant program.

## SEC filing metadata
- accession: 0001683168-25-000076
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-01-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825000076/0001683168-25-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825000076/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-000076
- JSON: https://secwatch.observer/filing/0001683168-25-000076.json
- Plain text: https://secwatch.observer/filing/0001683168-25-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.